References

  1. Golbe LI, Mark MH, Sage JI. Parkinson's Disease Handbook. A guide for patients and their families. New Brunswick, New Jersey. The American Parkinson Disease Association, Inc., 2009. Accessed September 21, 2015.
  2. National Parkinson Foundation. Parkinson's disease overview. Accessed September 21, 2015.
  3. NIHSeniorHealth. Parkinson's disease. Accessed September 21, 2015.
  4. American Parkinson Disease Association. Understanding the basics. Accessed September 21, 2015.
  5. U.S. National Library of Medicine. PubMed Health. Parkinson disease. Accessed September 21, 2015.
  6. Parkinson's Disease Foundation. Understanding Parkinson's. Accessed September 21, 2015.
  7. Friedlander AH, Mahler M, Norman KM, et al. Parkinson disease: systemic and orofacial manifestations, medical and dental management. J Am Dent Assoc. 2009 Jun;140(6):658-69.
  8. Parkinson's Action Network (PAN). Parkinson’s Disease and Parkinsonism: Are They the Same? Accessed September 22, 2015.
  9. Parkinson J. Project Gutenberg's: An essay on the shaking palsy. London. Whittingham and Rowland, 1817. Accessed September 21, 2015.
  10. Goetz CG. Jean-Martin Charcot and movement disorders: Neurological legacies to the 21st century. International Parkinson and Movement Disorder Society, 2009. Accessed September 21, 2015.
  11. Wirdefeldt K, Adami HO, Cole P, et al. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011 Jun;26 Suppl 1:S1-58.
  12. American Parkinson Disease Association. PD prevalence facts: Where the U.S. stands. American Parkinson Disease Association newsletter, summer 2013. Accessed September 21, 2015.
  13. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007 Jan 30;68(5):384-6.
  14. Schapira AH. Etiology of Parkinson's disease. Neurology. 2006 May 23;66(10 Suppl 4):S10-23.
  15. Martin I, Dawson VL, Dawson TM. Recent advances in the genetics of Parkinson's disease. Annu Rev Genomics Hum Genet. 2011;12:301-25.
  16. Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson's disease: progress and therapeutic implications. Mov Disord. 2013 Jan;28(1):14-23.
  17. Martin LJ. Biology of mitochondria in neurodegenerative diseases. Prog Mol Biol Transl Sci. 2012;107:355-415.
  18. Elbaz A, Moisan F. Update in the epidemiology of Parkinson's disease. Curr Opin Neurol. 2008 Aug;21(4):454-60.
  19. American Parkinson Disease Association: National Young Onset Center. What you should know about early onset Parkinson's disease. Accessed September 21, 2015.
  20. Shulman LM. Is there a connection between estrogen and Parkinson's disease? Parkinsonism Relat Disord. 2002 Jun;8(5):289-95.
  21. Jafari S, Etminan M, Aminzadeh F, et al. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord. 2013 Aug;28(9):1222-9.
  22. Dirks SJ, Paunovich ED, Terezhalmy GT, et al. The patient with Parkinson's disease. Quintessence Int. 2003 May;34(5):379-93.
  23. O'Loughlin M, Criddle LM. A 79-year-old man with an impalement injury of his face. J Emerg Nurs. 2004 Aug;30(4):303-6.
  24. Cianci H, Cloete L, Gardner J, et al. Activities of daily living: Practical pointers for Parkinson's disease. Miami, FL. National Parkinson Foundation. Accessed September 21, 2015.
  25. Goldstein DS, Eldadah BA, Holmes C, et al. Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension. 2005 Dec;46(6):1333-9.
  26. Janvin CC, Aarsland D, Larsen JP. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol. 2005 Sep;18(3):149-54.
  27. Huber MA. Parkinson's disease and oral health. Educational supplement #7. Staten Island, NY. The American Parkinson Disease Association, Inc., 2007. Accessed September 21, 2015.
  28. Persson M, Osterberg T, Granerus AK, et al. Influence of Parkinson's disease on oral health. Acta Odontol Scand. 1992 Feb;50(1):37-42.
  29. Hanaoka A, Kashihara K. Increased frequencies of caries, periodontal disease and tooth loss in patients with Parkinson's disease. J Clin Neurosci. 2009 Oct;16(10):1279-82.
  30. Schwarz J, Heimhilger E, Storch A. Increased periodontal pathology in Parkinson's disease. J Neurol. 2006 May;253(5):608-11.
  31. Müller T, Palluch R, Jackowski J. Caries and periodontal disease in patients with Parkinson's disease. Spec Care Dentist. 2011 Sep-Oct;31(5):178-81.
  32. Bakke M, Larsen SL, Lautrup C, et al. Orofacial function and oral health in patients with Parkinson's disease. Eur J Oral Sci. 2011 Feb;119(1):27-32.
  33. Nakayama Y, Washio M, Mori M. Oral health conditions in patients with Parkinson's disease. J Epidemiol. 2004 Sep;14(5):143-50.
  34. Featherstone JD, Domejean-Orliaguet S, Jenson L, et al. Caries risk assessment in practice for age 6 through adult. J Calif Dent Assoc. 2007 Oct;35(10):703-7, 710-3.
  35. Proulx M, de Courval FP, Wiseman MA, et al. Salivary production in Parkinson's disease. Mov Disord. 2005 Feb;20(2):204-7.
  36. U.S. Department of Veterans Affairs. Parkinson's disease research, education and clinical centers. Accessed August 20, 2015.
  37. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427-42.
  38. The five stages of Parkinson's disease. Palm Desert, CA. Parkinson’s Resource Organization, 2002. Accessed September 21, 2015.
  39. Oberdorf J, Schmidt P. Improving Care for People with Parkinson's Disease. Miami: National Parkinson Foundation; 2010.
  40. National Parkinson Foundation. How is PD treated. Accessed September 21, 2015.
  41. Semenchuk MR. Medical management of Parkinson's disease. Educational supplement #13. Staten Island, NY. American Parkinson Disease Association Inc., 2012. Accessed September 21, 2015.
  42. DeBowes SL, Tolle SL, Bruhn AM. Parkinson's disease: considerations for dental hygienists. Int J Dent Hyg. 2013 Feb;11(1):15-21.
  43. Clarke CE, Davies P. Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):590-4.
  44. Stocchi F. Optimising levodopa therapy for the management of Parkinson's disease. J Neurol. 2005 Oct;252 Suppl 4:IV43-IV48.
  45. Parkinson's Disease Foundation. Prescription medications. Accessed September 21, 2015.
  46. Wynn RL, Meiller TF, Crossley HL. Drug information handbook for dentistry: including oral medicine for medically-compromised patients & specific oral conditions. 18th ed. Hudson, OH. Lexicomp, 2012.
  47. Lundbeck. NORTHERA: Full prescribing information, 2014. Accessed September 21, 2015.
  48. AbbVie Inc. DUOPA: Highlights of prescribing information, 2015. Accessed September 21, 2015.
  49. Impax Pharmaceuticals. RYTARY: Highlights of prescribing information, 2015. Accessed September 21, 2015.
  50. Little JW, Falace DA, Miller CS, et al. Dental management of the medically compromised patient. Neurologic disorders. 8th Ed. St. Louis, MO. Elsevier Mosby, 2013:516-9.
  51. Becker DE. Adverse drug interactions. Anesth Prog. Spring 2011;58(1):31-41.
  52. American Parkinson Disease Association. Deep brain stimulation. American Parkinson Disease Association newsletter, summer 2013. Accessed September 21, 2015.
  53. Okun MS, Zeilman PR. Parkinson's disease: Guide to deep brain stimulation therapy. 2nd ed. Miami, FL. National Parkinson Foundation, 2014. Accessed September 21, 2015.
  54. Pahwa R, Lyons KE, Nazzaro JM. Deep brain stimulation for Parkinson's disease. Kansas City, KS: University of Kansas Medical Center, 2007. Accessed September 25, 2015.
  55. Medtronic. Important Safety Information. Medtronic DBS Therapy for Parkinson’s Disease, Tremor, and Dystonia: Patients should always discuss the potential risks and benefits with a physician. Last updated: 9 Oct 2014. Accessed September 22, 2015.
  56. Shu HF, Yang T, Yu SX, et al. Aerobic exercise for Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2014 Jul 1;9(7):e100503.
  57. Canning CG, Sherrington C, Lord SR, et al. Exercise for falls prevention in Parkinson disease: a randomized controlled trial. Neurology. 2015 Jan 20;84(3):304-12.
  58. Ellis T, DeAngelis T. Too little exercise and too much sitting: A recipe for change. Educational supplement #28. Staten Island, NY. American Parkinson Disease Association, 2013. Accessed September 21, 2015.
  59. Grover S, Rhodus NL. Dental management of Parkinson's disease. Northwest Dent. 2011 Nov-Dec;90(6):13-9.
  60. Blumin JH, Pcolinsky DE, Atkins JP. Laryngeal findings in advanced Parkinson's disease. Ann Otol Rhinol Laryngol. 2004 Apr;113(4):253-8.
  61. Dougall A, Fiske J. Access to special care dentistry, part 9. Special care dentistry services for older people. Br Dent J. 2008 Oct 25;205(8):421-34.
  62. Nadig RR, Usha G, Kumar V, et al. Geriatric restorative care - the need, the demand and the challenges. J Conserv Dent. 2011 Jul;14(3):208-14.
  63. Burgess JO, Gallo JR. Treating root-surface caries. Dent Clin North Am. 2002 Apr;46(2):385-404, vii-viii.
  64. Olsen P. Maintaining independence in Parkinson's disease. Educational supplement #9. Staten Island, NY. American Parkinson Disease Association, 2011. Accessed September 21, 2015.
  65. Alzheimer Society Canada. Person-centred language guidelines. Accessed September 21, 2015.
  66. Snow K. People first language. 2008. Accessed September 21, 2015.

Additional Resources

  • No Additional Resources Available